Pulmonary hypertension trials: current end points are flawed, but what are the alternatives?
Roberts
Kari
K
Preston
Ioana
I
Hill
Nicholas S
NS
D000203:Activities of Daily Living / Q000145:classification; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D002423:Cause of Death; D002986:Clinical Trials as Topic; D011464:Epoprostenol / Q000008:administration & dosage*; D005080:Exercise Test / Q000187:drug effects; D005500:Follow-Up Studies; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D016019:Survival Analysis; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D011464:Epoprostenol